BioCorRx (BICX) Stock Statistics & Valuation Metrics

BioCorRx has a market cap or net worth of $8.49M. The enterprise value is $13.26M.

BioCorRx has 18,911,995 shares outstanding. The number of shares has decreased by -2.65% in one year.

BioCorRx’s return on equity (ROE) is 0.42 and return on invested capital (ROIC) is 97.66%.

The current PE Ratio of BioCorRx is ―. BioCorRx’s PEG ratio is ―.

In the last 12 months, BioCorRx had revenue of 7.67K and earned -5.11M in profits. Earnings per share was -0.49.

In the last 12 months, operating cash flow was -1.42M and capital expenditures 0.00, giving a free cash flow of -1.42M billion.

BioCorRx pays an annual dividend of ―, resulting in a dividend yield of ―

BioCorRx upcoming earnings date is Aug 17, 2026, TBA (Confirmed).

BioCorRx as a current ratio of 0.01, with Debt / Equity ratio of -23.75%

In the past 12 months, BioCorRx has paid 0.00 in taxes.

BioCorRx EV to EBITDA ratio is -1.87, with an EV/FCF ratio of -6.11.

BioCorRx has $111.87K in cash and marketable securities with $2.90M in debt, giving a net cash position of $2.79M billion.

Gross margin is 82.61%, with operating margin of -66829.81%, and net profit margin of -66616.10%.

The average price target for BioCorRx is ―, which is 11.43% higher than the current price. The consensus rating is ―